New data indicates two doses of LSD reduced measures of anxiety compared to placebo, with the effects lasting up to 16 weeks

Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety. The results indicate one to two LSD sessions can generate rapid and sustained reductions to anxiety, however, significantly larger trials will be needed to validate these findings.

Continue Reading

Category: Science

Tags: , , , ,